Semiconductor & Technology Specialist, Ingenuity

William Keating

Dr. William Keating is a highly experienced senior executive with over 25 years experience in the IT/Semiconductor Industry. The majority of Dr. Keating's career was spent at Intel Corporation where he held senior leadership positions in Europe, the US and Asia from 1992 through 2014. He served as Intel's IT Director for APAC, China & Japan from 2005 through 2014 when he was based in Hong Kong and was responsible for the IT systems (Infrastructure, Networks, Data Centres, ERP, Sales & Marketing systems, Business Intelligence etc. ) for all of Intel's offices & factories through the region. From 1998 through 2005, he was the founder & director of an internal IT Consulting Organisation (IT Flex Services), a 500-person team which remains a core part of the Intel IT Organisation to this day. Dr. Keating's first 6 years at Intel were spent in charge of the Factory Automation Systems (Robotics, Databases, Networks, Servers, Clients etc.) supporting Intel's then state-of-the-art 200mm factory network. Since leaving Intel in 2014, Dr Keating established his own Technology Research & Consulting Company (www.ingenuity.hk) where he focuses on the products, roadmaps & technologies of companies such as Intel, AMD, Samsung, Apple, Micron- as well as the key equipment suppliers to those companies e.g. ASML, AMAT, Canon, Nikon etc. Dr. Keating specializes in niche topics of high significance within the semiconductor industry. These include the future of Moore's Law and in particular the significance of Lithography in maintaining Moore's Law (EUV, SDA, NanoImprint), the role & growth of the GPU in specialised applications such as Deep Learning (Neural Networks) for Voice, Image & Pattern recognition at companies such as Facebook, Google & Baidu. He also holds regular discussions on the future of memory, in particular the rise of 3D NAND and the emergence of new memory technologies such as 3D Xpoint.

Semiconductor & Technology Specialist

ASML Q325 Earnings In Line, Outlook More Positive Compared To Prior Quarter, Big Emphasis On AI

LRCX Q325. Solid Results, Outlook But China Exposure Is A Glaring Red Flag

Substrate. ASML, TSMC Slayer Or Ideological Pipe Dream?

Tokyo Electron — Navigating the Cycle, Leveraged to AI/HBM Growth

LRCX FY 25Q4. Record Quarter, Record Year But Beware Tariff Threats & China Exposure

AMAT Q325. Tanking On Tepid Leading Edge Outlook & China Woes

Tokyo Electron (8035 JP): Why the Big Downward Revision?

Ingenuity

Our focus is exclusively on in-depth research & consulting in the broader semiconductor industry. We focus on the key players, namely Intel, Micron, Qualcomm, Apple, Samsung, NVIDIA, AMD, TSMC & Global Foundries - as well as some of the lesser known, but nonetheless critical, companies such as ASML (for EUV), Mellanox, Cavium, Xilinx etc. We specialise in their products, roadmaps, process technologies, competitive advantages & threats etc. We also help our clients understand the implications of new and emerging technologies, e.g. 3D X-Point, 3D NAND, Carbon Nanotubes, Autonomous Driving, Graphene, Silicon Photonics, Wafer-Level Optics, Artificial Intelligence, FPGA, GPU, ASIC etc. 

Semiconductor Analysis & Research

Thematic (Sector/Industry)

Zimbabwe Semiconductors and semiconductor equipment / Thematic (Sector/Industry)

<ul>
<li>Q225 WFE billing amounted to $33 billion, up 24% YoY and up 3% QoQ. China was the biggest spender with billings of $11.36 billion, +11% QoQ, albeit down 7% YoY</li>
<li>A US select committee on China WFE spending, published on October 7 last, highlights multiple gaps with existing US restrictions on China WFE and proposes nine separate remedies</li>
<li>Remedies include sweeping China <em><strong>country-wide</strong></em> bans, bans on related components, consumables &amp; deploying "incentives &amp; leverage" with allies so they follow suit. Still wondering about China's surprise rare earth move?</li>
</ul>


Q225 WFE billing amounted to $33 billion, up 24% YoY and up 3% QoQ. China was the biggest spender with billings of $11.36 billion, +11% QoQ, albeit down 7% YoY
A US select committee on China WFE spending, published on October 7 last, highlights multiple gaps with existing US restrictions on China WFE and proposes nine separate remedies
Remedies include sweeping China country-wide bans, bans on related components, consumables &amp; deploying "incentives &amp; leverage" with allies so they follow suit. Still wondering about China's surprise rare earth move?


Semiconductor WFE. China Retains #1 Spending Slot In Q225, US Mulls Yet Further Sweeping Sanctions